Click for best price
Stem Cell Therapy for Multiple Sclerosis Market Size, Share 2023
Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Multiple Sclerosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Multiple Sclerosis. This report contains market size and forecasts of Stem Cell Therapy for Multiple Sclerosis in global, including the following market information:
Global Stem Cell Therapy for Multiple Sclerosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Stem Cell Therapy for Multiple Sclerosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The introduction of mesenchymal stem cells therapy is one of the most promising investigational approach to treat multiple sclerosis, the global multiple sclerosis market will witness growth in the forthcoming years. it has been observed that the American cryostem and celgene cellular therapeutics have their stem cell therapy candidates for the treatment of multiple sclerosis in phase I stage of development.
We surveyed the Stem Cell Therapy for Multiple Sclerosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Therapy for Multiple Sclerosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Multiple Sclerosis Market Segment Percentages, by Type, 2022 (%)
Intravenous
Intracerebroventricular
Global Stem Cell Therapy for Multiple Sclerosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Multiple Sclerosis Market Segment Percentages, by Application, 2022 (%)
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Progressive Relapsing Multiple Sclerosis (PRMS)
Global Stem Cell Therapy for Multiple Sclerosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Stem Cell Therapy for Multiple Sclerosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Therapy for Multiple Sclerosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Stem Cell Therapy for Multiple Sclerosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
American CryoStem
Athersys
Celgene Cellular Therapeutics
Cell Cure Neurosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Stem Cell Therapy for Multiple Sclerosis, market overview.
Chapter 2: Global Stem Cell Therapy for Multiple Sclerosis market size in revenue.
Chapter 3: Detailed analysis of Stem Cell Therapy for Multiple Sclerosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stem Cell Therapy for Multiple Sclerosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Stem Cell Therapy for Multiple Sclerosis Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Stem Cell Therapy for Multiple Sclerosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Stem Cell Therapy for Multiple Sclerosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Stem Cell Therapy for Multiple Sclerosis Overall Market Size
2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size: 2022 VS 2029
2.2 Global Stem Cell Therapy for Multiple Sclerosis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cell Therapy for Multiple Sclerosis Players in Global Market
3.2 Top Global Stem Cell Therapy for Multiple Sclerosis Companies Ranked by Revenue
3.3 Global Stem Cell Therapy for Multiple Sclerosis Revenue by Companies
3.4 Top 3 and Top 5 Stem Cell Therapy for Multiple Sclerosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Stem Cell Therapy for Multiple Sclerosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cell Therapy for Multiple Sclerosis Players in Global Market
3.6.1 List of Global Tier 1 Stem Cell Therapy for Multiple Sclerosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Stem Cell Therapy for Multiple Sclerosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Stem Cell Therapy for Multiple Sclerosis Market Size Markets, 2022 & 2029
4.1.2 Intravenous
4.1.3 Intracerebroventricular
4.2 By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue & Forecasts
4.2.1 By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2023
4.2.2 By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2024-2029
4.2.3 By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Stem Cell Therapy for Multiple Sclerosis Market Size, 2022 & 2029
5.1.2 Relapsing-Remitting Multiple Sclerosis (RRMS)
5.1.3 Primary Progressive Multiple Sclerosis (PPMS)
5.1.4 Secondary Progressive Multiple Sclerosis (SPMS)
5.1.5 Progressive Relapsing Multiple Sclerosis (PRMS)
5.2 By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue & Forecasts
5.2.1 By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2023
5.2.2 By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2024-2029
5.2.3 By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Stem Cell Therapy for Multiple Sclerosis Market Size, 2022 & 2029
6.2 By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue & Forecasts
6.2.1 By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2023
6.2.2 By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2024-2029
6.2.3 By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2029
6.3.2 US Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.3.3 Canada Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.3.4 Mexico Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2029
6.4.2 Germany Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4.3 France Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4.4 U.K. Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4.5 Italy Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4.6 Russia Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4.7 Nordic Countries Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.4.8 Benelux Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2029
6.5.2 China Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.5.3 Japan Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.5.4 South Korea Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.5.5 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.5.6 India Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2029
6.6.2 Brazil Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.6.3 Argentina Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2029
6.7.2 Turkey Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.7.3 Israel Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.7.4 Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
6.7.5 UAE Stem Cell Therapy for Multiple Sclerosis Market Size, 2018-2029
7 Stem Cell Therapy for Multiple Sclerosis Companies Profiles
7.1 American CryoStem
7.1.1 American CryoStem Company Summary
7.1.2 American CryoStem Business Overview
7.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Major Product Offerings
7.1.4 American CryoStem Stem Cell Therapy for Multiple Sclerosis Revenue in Global Market (2018-2023)
7.1.5 American CryoStem Key News & Latest Developments
7.2 Athersys
7.2.1 Athersys Company Summary
7.2.2 Athersys Business Overview
7.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Major Product Offerings
7.2.4 Athersys Stem Cell Therapy for Multiple Sclerosis Revenue in Global Market (2018-2023)
7.2.5 Athersys Key News & Latest Developments
7.3 Celgene Cellular Therapeutics
7.3.1 Celgene Cellular Therapeutics Company Summary
7.3.2 Celgene Cellular Therapeutics Business Overview
7.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Major Product Offerings
7.3.4 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Revenue in Global Market (2018-2023)
7.3.5 Celgene Cellular Therapeutics Key News & Latest Developments
7.4 Cell Cure Neurosciences
7.4.1 Cell Cure Neurosciences Company Summary
7.4.2 Cell Cure Neurosciences Business Overview
7.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Major Product Offerings
7.4.4 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Revenue in Global Market (2018-2023)
7.4.5 Cell Cure Neurosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Stem Cell Therapy for Multiple Sclerosis Market Opportunities & Trends in Global Market
Table 2. Stem Cell Therapy for Multiple Sclerosis Market Drivers in Global Market
Table 3. Stem Cell Therapy for Multiple Sclerosis Market Restraints in Global Market
Table 4. Key Players of Stem Cell Therapy for Multiple Sclerosis in Global Market
Table 5. Top Stem Cell Therapy for Multiple Sclerosis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Stem Cell Therapy for Multiple Sclerosis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Stem Cell Therapy for Multiple Sclerosis Product Type
Table 9. List of Global Tier 1 Stem Cell Therapy for Multiple Sclerosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stem Cell Therapy for Multiple Sclerosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Stem Cell Therapy for Multiple Sclerosis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Stem Cell Therapy for Multiple Sclerosis Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Stem Cell Therapy for Multiple Sclerosis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Stem Cell Therapy for Multiple Sclerosis Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2024-2029
Table 30. American CryoStem Company Summary
Table 31. American CryoStem Stem Cell Therapy for Multiple Sclerosis Product Offerings
Table 32. American CryoStem Stem Cell Therapy for Multiple Sclerosis Revenue (US$, Mn) & (2018-2023)
Table 33. American CryoStem Key News & Latest Developments
Table 34. Athersys Company Summary
Table 35. Athersys Stem Cell Therapy for Multiple Sclerosis Product Offerings
Table 36. Athersys Stem Cell Therapy for Multiple Sclerosis Revenue (US$, Mn) & (2018-2023)
Table 37. Athersys Key News & Latest Developments
Table 38. Celgene Cellular Therapeutics Company Summary
Table 39. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product Offerings
Table 40. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Cellular Therapeutics Key News & Latest Developments
Table 42. Cell Cure Neurosciences Company Summary
Table 43. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product Offerings
Table 44. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Revenue (US$, Mn) & (2018-2023)
Table 45. Cell Cure Neurosciences Key News & Latest Developments
List of Figures
Figure 1. Stem Cell Therapy for Multiple Sclerosis Segment by Type in 2022
Figure 2. Stem Cell Therapy for Multiple Sclerosis Segment by Application in 2022
Figure 3. Global Stem Cell Therapy for Multiple Sclerosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Stem Cell Therapy for Multiple Sclerosis Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2022
Figure 8. By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 9. By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 10. By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 12. By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 14. By Region - Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 15. By Country - North America Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 16. US Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 20. Germany Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 21. France Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 28. China Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 32. India Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 34. Brazil Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Revenue Market Share, 2018-2029
Figure 37. Turkey Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Stem Cell Therapy for Multiple Sclerosis Revenue, (US$, Mn), 2018-2029
Figure 41. American CryoStem Stem Cell Therapy for Multiple Sclerosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Athersys Stem Cell Therapy for Multiple Sclerosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
